nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalidixic Acid—Cranial nerve paralysis—Vincristine—muscle cancer	0.189	0.189	CcSEcCtD
Nalidixic Acid—Cranial nerve paralysis—Methotrexate—muscle cancer	0.0919	0.0919	CcSEcCtD
Nalidixic Acid—Metabolic acidosis—Etoposide—muscle cancer	0.0448	0.0448	CcSEcCtD
Nalidixic Acid—Optic neuritis—Etoposide—muscle cancer	0.0288	0.0288	CcSEcCtD
Nalidixic Acid—Optic neuritis—Doxorubicin—muscle cancer	0.0149	0.0149	CcSEcCtD
Nalidixic Acid—Swelling—Etoposide—muscle cancer	0.0146	0.0146	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.0136	0.0136	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Etoposide—muscle cancer	0.0133	0.0133	CcSEcCtD
Nalidixic Acid—Blister—Doxorubicin—muscle cancer	0.0127	0.0127	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Vincristine—muscle cancer	0.0125	0.0125	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Vincristine—muscle cancer	0.012	0.012	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Dactinomycin—muscle cancer	0.0116	0.0116	CcSEcCtD
Nalidixic Acid—Erythema—Dactinomycin—muscle cancer	0.0107	0.0107	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.00981	0.00981	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Etoposide—muscle cancer	0.0097	0.0097	CcSEcCtD
Nalidixic Acid—Leukopenia—Dactinomycin—muscle cancer	0.00956	0.00956	CcSEcCtD
Nalidixic Acid—Vertigo—Vincristine—muscle cancer	0.00858	0.00858	CcSEcCtD
Nalidixic Acid—Leukopenia—Vincristine—muscle cancer	0.00854	0.00854	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Dactinomycin—muscle cancer	0.00854	0.00854	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Etoposide—muscle cancer	0.0084	0.0084	CcSEcCtD
Nalidixic Acid—Convulsion—Vincristine—muscle cancer	0.00827	0.00827	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Methotrexate—muscle cancer	0.00795	0.00795	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00794	0.00794	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Vincristine—muscle cancer	0.00779	0.00779	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Vincristine—muscle cancer	0.00763	0.00763	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00713	0.00713	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Vincristine—muscle cancer	0.0071	0.0071	CcSEcCtD
Nalidixic Acid—Paraesthesia—Vincristine—muscle cancer	0.007	0.007	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Doxorubicin—muscle cancer	0.00697	0.00697	CcSEcCtD
Nalidixic Acid—Vertigo—Etoposide—muscle cancer	0.00695	0.00695	CcSEcCtD
Nalidixic Acid—Leukopenia—Etoposide—muscle cancer	0.00692	0.00692	CcSEcCtD
Nalidixic Acid—Abdominal pain—Dactinomycin—muscle cancer	0.00689	0.00689	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.00688	0.00688	CcSEcCtD
Nalidixic Acid—Convulsion—Etoposide—muscle cancer	0.0067	0.0067	CcSEcCtD
Nalidixic Acid—Diplopia—Doxorubicin—muscle cancer	0.00666	0.00666	CcSEcCtD
Nalidixic Acid—Eosinophilia—Methotrexate—muscle cancer	0.00658	0.00658	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Vincristine—muscle cancer	0.00637	0.00637	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Etoposide—muscle cancer	0.00631	0.00631	CcSEcCtD
Nalidixic Acid—Asthenia—Dactinomycin—muscle cancer	0.00626	0.00626	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Etoposide—muscle cancer	0.00618	0.00618	CcSEcCtD
Nalidixic Acid—Abdominal pain—Vincristine—muscle cancer	0.00616	0.00616	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Methotrexate—muscle cancer	0.00607	0.00607	CcSEcCtD
Nalidixic Acid—Diarrhoea—Dactinomycin—muscle cancer	0.00597	0.00597	CcSEcCtD
Nalidixic Acid—Drowsiness—Methotrexate—muscle cancer	0.00593	0.00593	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00588	0.00588	CcSEcCtD
Nalidixic Acid—Eosinophilia—Doxorubicin—muscle cancer	0.0057	0.0057	CcSEcCtD
Nalidixic Acid—Paraesthesia—Etoposide—muscle cancer	0.00567	0.00567	CcSEcCtD
Nalidixic Acid—Somnolence—Etoposide—muscle cancer	0.00561	0.00561	CcSEcCtD
Nalidixic Acid—Asthenia—Vincristine—muscle cancer	0.00559	0.00559	CcSEcCtD
Nalidixic Acid—Vomiting—Dactinomycin—muscle cancer	0.00554	0.00554	CcSEcCtD
Nalidixic Acid—Rash—Dactinomycin—muscle cancer	0.0055	0.0055	CcSEcCtD
Nalidixic Acid—Diarrhoea—Vincristine—muscle cancer	0.00533	0.00533	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00525	0.00525	CcSEcCtD
Nalidixic Acid—Nausea—Dactinomycin—muscle cancer	0.00518	0.00518	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Etoposide—muscle cancer	0.00516	0.00516	CcSEcCtD
Nalidixic Acid—Dizziness—Vincristine—muscle cancer	0.00515	0.00515	CcSEcCtD
Nalidixic Acid—Drowsiness—Doxorubicin—muscle cancer	0.00513	0.00513	CcSEcCtD
Nalidixic Acid—Visual impairment—Methotrexate—muscle cancer	0.00513	0.00513	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00509	0.00509	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Methotrexate—muscle cancer	0.00503	0.00503	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00503	0.00503	CcSEcCtD
Nalidixic Acid—Urticaria—Etoposide—muscle cancer	0.00501	0.00501	CcSEcCtD
Nalidixic Acid—Abdominal pain—Etoposide—muscle cancer	0.00499	0.00499	CcSEcCtD
Nalidixic Acid—Vomiting—Vincristine—muscle cancer	0.00495	0.00495	CcSEcCtD
Nalidixic Acid—Rash—Vincristine—muscle cancer	0.00491	0.00491	CcSEcCtD
Nalidixic Acid—Dermatitis—Vincristine—muscle cancer	0.00491	0.00491	CcSEcCtD
Nalidixic Acid—Headache—Vincristine—muscle cancer	0.00488	0.00488	CcSEcCtD
Nalidixic Acid—Erythema—Methotrexate—muscle cancer	0.00463	0.00463	CcSEcCtD
Nalidixic Acid—Nausea—Vincristine—muscle cancer	0.00463	0.00463	CcSEcCtD
Nalidixic Acid—Asthenia—Etoposide—muscle cancer	0.00453	0.00453	CcSEcCtD
Nalidixic Acid—Pruritus—Etoposide—muscle cancer	0.00447	0.00447	CcSEcCtD
Nalidixic Acid—Visual impairment—Doxorubicin—muscle cancer	0.00444	0.00444	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Doxorubicin—muscle cancer	0.00436	0.00436	CcSEcCtD
Nalidixic Acid—Diarrhoea—Etoposide—muscle cancer	0.00432	0.00432	CcSEcCtD
Nalidixic Acid—Dizziness—Etoposide—muscle cancer	0.00417	0.00417	CcSEcCtD
Nalidixic Acid—Vertigo—Methotrexate—muscle cancer	0.00416	0.00416	CcSEcCtD
Nalidixic Acid—Leukopenia—Methotrexate—muscle cancer	0.00415	0.00415	CcSEcCtD
Nalidixic Acid—Convulsion—Methotrexate—muscle cancer	0.00401	0.00401	CcSEcCtD
Nalidixic Acid—Vomiting—Etoposide—muscle cancer	0.00401	0.00401	CcSEcCtD
Nalidixic Acid—Erythema—Doxorubicin—muscle cancer	0.00401	0.00401	CcSEcCtD
Nalidixic Acid—Rash—Etoposide—muscle cancer	0.00398	0.00398	CcSEcCtD
Nalidixic Acid—Dermatitis—Etoposide—muscle cancer	0.00398	0.00398	CcSEcCtD
Nalidixic Acid—Headache—Etoposide—muscle cancer	0.00395	0.00395	CcSEcCtD
Nalidixic Acid—Arthralgia—Methotrexate—muscle cancer	0.00394	0.00394	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Methotrexate—muscle cancer	0.00378	0.00378	CcSEcCtD
Nalidixic Acid—Nausea—Etoposide—muscle cancer	0.00375	0.00375	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Methotrexate—muscle cancer	0.0037	0.0037	CcSEcCtD
Nalidixic Acid—Vertigo—Doxorubicin—muscle cancer	0.0036	0.0036	CcSEcCtD
Nalidixic Acid—Leukopenia—Doxorubicin—muscle cancer	0.00359	0.00359	CcSEcCtD
Nalidixic Acid—Convulsion—Doxorubicin—muscle cancer	0.00348	0.00348	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00344	0.00344	CcSEcCtD
Nalidixic Acid—Arthralgia—Doxorubicin—muscle cancer	0.00341	0.00341	CcSEcCtD
Nalidixic Acid—Paraesthesia—Methotrexate—muscle cancer	0.00339	0.00339	CcSEcCtD
Nalidixic Acid—Somnolence—Methotrexate—muscle cancer	0.00336	0.00336	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Doxorubicin—muscle cancer	0.00327	0.00327	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Doxorubicin—muscle cancer	0.0032	0.0032	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Methotrexate—muscle cancer	0.00309	0.00309	CcSEcCtD
Nalidixic Acid—Urticaria—Methotrexate—muscle cancer	0.003	0.003	CcSEcCtD
Nalidixic Acid—Abdominal pain—Methotrexate—muscle cancer	0.00299	0.00299	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00298	0.00298	CcSEcCtD
Nalidixic Acid—Paraesthesia—Doxorubicin—muscle cancer	0.00294	0.00294	CcSEcCtD
Nalidixic Acid—Somnolence—Doxorubicin—muscle cancer	0.00291	0.00291	CcSEcCtD
Nalidixic Acid—Asthenia—Methotrexate—muscle cancer	0.00271	0.00271	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00268	0.00268	CcSEcCtD
Nalidixic Acid—Pruritus—Methotrexate—muscle cancer	0.00267	0.00267	CcSEcCtD
Nalidixic Acid—Urticaria—Doxorubicin—muscle cancer	0.0026	0.0026	CcSEcCtD
Nalidixic Acid—Abdominal pain—Doxorubicin—muscle cancer	0.00259	0.00259	CcSEcCtD
Nalidixic Acid—Diarrhoea—Methotrexate—muscle cancer	0.00259	0.00259	CcSEcCtD
Nalidixic Acid—Dizziness—Methotrexate—muscle cancer	0.0025	0.0025	CcSEcCtD
Nalidixic Acid—Vomiting—Methotrexate—muscle cancer	0.0024	0.0024	CcSEcCtD
Nalidixic Acid—Rash—Methotrexate—muscle cancer	0.00238	0.00238	CcSEcCtD
Nalidixic Acid—Dermatitis—Methotrexate—muscle cancer	0.00238	0.00238	CcSEcCtD
Nalidixic Acid—Headache—Methotrexate—muscle cancer	0.00237	0.00237	CcSEcCtD
Nalidixic Acid—Asthenia—Doxorubicin—muscle cancer	0.00235	0.00235	CcSEcCtD
Nalidixic Acid—Pruritus—Doxorubicin—muscle cancer	0.00232	0.00232	CcSEcCtD
Nalidixic Acid—Nausea—Methotrexate—muscle cancer	0.00225	0.00225	CcSEcCtD
Nalidixic Acid—Diarrhoea—Doxorubicin—muscle cancer	0.00224	0.00224	CcSEcCtD
Nalidixic Acid—Dizziness—Doxorubicin—muscle cancer	0.00216	0.00216	CcSEcCtD
Nalidixic Acid—Vomiting—Doxorubicin—muscle cancer	0.00208	0.00208	CcSEcCtD
Nalidixic Acid—Rash—Doxorubicin—muscle cancer	0.00206	0.00206	CcSEcCtD
Nalidixic Acid—Dermatitis—Doxorubicin—muscle cancer	0.00206	0.00206	CcSEcCtD
Nalidixic Acid—Headache—Doxorubicin—muscle cancer	0.00205	0.00205	CcSEcCtD
Nalidixic Acid—Nausea—Doxorubicin—muscle cancer	0.00194	0.00194	CcSEcCtD
